Moreover, it was also reported that activation of AMPK by metformin could also be used as a potential strategy for prevention of cancer metastasis through disruption of E-cadherin-mediated cell–cell adhesion by blocking the expression of tumor invasion-related signaling molecules, such as TGF-β and Vimentin [34, 35]. Here, CDH1 is linked to neoplasm.